Arabidopsis thaliana CRT1 (compromised for recognition of Turnip Crinkle Virus) was previously shown to be required for effector-triggered immunity. Sequence analyses previously revealed that CRT1 contains the ATPase and S5 domains characteristic of Microchidia (MORC) proteins; these proteins are associated with DNA modification and repair. Here we show that CRT1 and its closest homologue, CRH1, are also required for pathogen-associated molecular pattern (PAMP)-triggered immunity, basal resistance, nonhost resistance and systemic acquired resistance. Consistent with its role in PAMP-triggered immunity, CRT1 interacted with the PAMP recognition receptor FLS2. Subcellular fractionation and transmission electron microscopy detected a subpopulation of CRT1 in the nucleus, whose levels increased following PAMP treatment or infection with an avirulent pathogen. These results, combined with the demonstration that CRT1 binds DNA, exhibits endonuclease activity, and affects tolerance to the DNA-damaging agent mitomycin C, argue that this prototypic eukaryotic member of the MORC superfamily has important nuclear functions during immune response activation.
P lants have evolved various defenses to protect themselves from a constant barrage of potentially pathogenic microorganisms. The current model for plant disease resistance envisions a 'zig-zag' interplay between plant defences and pathogen counter defenses 1 . In the inoculated tissue, recognition of pathogen-associated molecular patterns (PAMPs) by extracellular surface receptors leads to activation of PAMPtriggered immunity (PTI). Although PTI is sufficient to prevent further colonization by many microbes, some pathogens have evolved effectors that suppress PTI. The resultant weak level of resistance exhibited by a host plant inoculated with such a pathogen has been defined as basal resistance 1 (it should be noted that some authors use PTI and basal resistance interchangeably 2 ). Whether such a pathogen can infect the host plant is then determined by whether the plant expresses a resistance (R) protein that directly or indirectly recognizes one of these effectors (also termed avirulence (Avr) factors) to induce effector-triggered immunity (ETI). In the absence of this Avr-R protein interaction, or if the pathogen produces additional effectors that suppress ETI, the virulence of the pathogen on its host will be promoted. Following PAMP-or R gene-mediated pathogen recognition, various defenses are activated in the infected tissue, including the accumulation of reactive oxygen species (ROS), salicylic acid (SA), and pathogenesis-related (PR) proteins 2 . ETI also is frequently associated with the development of a hypersensitive response (HR), in which necrotic lesions form at the site(s) of pathogen entry. Subsequently, PTI and ETI can trigger systemic SA accumulation and PR gene expression in the uninoculated (systemic) tissue, as well as a long-lasting, broad-based resistance to subsequent pathogen infection known as systemic acquired resistance (SAR) 2 .
An additional layer of resistance, termed non-host resistance, is likely the most common form protecting plants from the thousands of microorganisms they encounter 3 . Non-host resistance appears to have a critical role in preventing non-host fungal and oomycete pathogens from penetrating host cells, as the three Arabidopsis pen (penetration) mutants allowed enhanced entry of Erysiphe pisi, Phytophthora infestans and/or Blumeria graminis f. sp. hordei 4 . PEN1 is a syntaxin functioning in vesicle trafficking 5 , PEN2 is a b-glucosidase 6 mainly localized in peroxisomes and PEN3 is an ATP-binding cassette transporter 4 . The mechanism involved in non-host resistance is poorly understood. However, as it often requires the signalling components EDS1, SGT1 and HSP90, as well as the hormones SA and ethylene, it appears to overlap with those for PTI and ETI [7] [8] [9] [10] .
Turnip Crinkle Virus (TCV) is a carmovirus that infects most Arabidopsis ecotypes. We identified a resistant ecotype, Di-17, which contains an R gene, HRT (HR to TCV), that triggers HR development, defence gene expression and SA accumulation following TCV infection 11 . Plants lacking HRT fail to develop an HR after TCV infection and allow systemic viral spread, followed by death of the plant 11 . A genetic screen for mutants with compromised HRT-mediated resistance identified crt1 (compromised for recognition of TCV) 12 . CRT1 was subsequently shown to physically interact with HRT and ten other R proteins representing three different structural classes. This interaction appears to be dynamic as CRT1 bound inactive R proteins, but only poorly interacted with activated R proteins 13 . Analysis of the Arabidopsis genome revealed that CRT1 has two close (Z70% a.a. identity) and four distant (r50% a.a. identity) homologues. Partial silencing of CRT1's two closest homologues, CRH1 (CRT1 Homologue 1) and CRH2, in the crt1 background compromised TCV resistance to a greater extent than that displayed by crt1, suggesting that CRT1 and its closest homologues are functionally redundant and have an important role in ETI against TCV 12 . Cell death triggered by the R proteins ssi4 and RPS2 also was compromised by the crt1-1 mutation or silencing of CRT1 family members. Moreover, a double knockout (dKO) in the Col-0 background, crt1-2 crh1-1, which lacks CRT1 and its closest homologue, displayed compromised resistance to avirulent Pseudomonas syringae (Pst) and Hyaloperonospora arabidopsidis 13, 14 . Construction of a triple KO was not possible as the CRH2 KO was lethal in the homozygous state. Independent studies also have identified CRT1 as one of the only 11 genes whose knockout led to severe susceptibility to both virulent and avirulent H. arabidopsidis 14 . Together, these studies establish CRT1 as a key component in both ETI and basal resistance.
Sequence analysis indicated that CRT1 contains a 'GHKL' (Gyrase, Hsp90, Histidine Kinase, MutL) ATPase motif 15 and an S5-fold domain (383aa-458aa) 16 . These domains are characteristic of MORC (Microchidia) proteins, a subset of the GHKL ATPase superfamily 16 . MORC proteins are widely distributed in eukaryotes; they also are present in a wide range of prokaryotic species, although their distribution is sporadic 16 . Mouse MORC1, the first MORC protein identified, was shown to be required for meiotic nuclear division 17 . MutL, another MORC present in prokaryotes and eukaryotes, is a key enzyme involved in initiating replacement of mismatched nucleotides on the newly synthesized DNA strand 18 . Analysis of gene neighbourhoods in prokaryoytic operons containing MORC-encoding genes further suggested that these proteins are involved in restriction modification systems, the ancient self/nonself-recognition system in prokaryotes 16 . Interestingly, two recent mutant screens for gene silencing suppressors identified Arabidopsis CRT1 and its homologue CRH6 as new factors in altering DNA/ chromosome superstructure in response to epigenetic signals 19, 20 .
Here we demonstrate that CRT1 and its closest homologue, CRH1, are required for PTI, basal resistance, non-host resistance, and SAR. Immunoprecipitation (IP) assays indicated that CRT1 binds the PAMP receptor FLS2 in planta, and this interaction is not affected by flg22-induced activation of FLS2. The combined discoveries that CRT1 is a member of the MORC superfamily, a subpopulation of CRT1 is present in the nucleus, the level of nuclear-localized CRT1 increases upon activation of ETI and, to a lesser degree, PTI, CRT1 exhibits DNA/RNA-binding and endonuclease activities, and mutations in CRT1 and its closest homologue enhance tolerance to the DNA-damaging agent mitomycin C, suggest that CRT1 has an important function(s) in the nucleus, possibly associated with DNA recombination and repair (R/R) and/or chromatin structure. Together, these findings provide the first demonstration of CRT1's function(s) at multiple levels of plant immunity, and they provide key insights into how this prototypic eukaryotic MORC functions during immune responses in plants. In turn, these results may provide important clues about the function of CRT1's distant human counterpart in mammalian immunity.
Results
CRT1 is involved in basal resistance and PTI against viral and bacterial pathogens. To assess whether CRT1 and CRH1 are required for basal resistance, TCV resistance was assessed in the dKO, which, lacks HRT. crt1-2 crh1-1 developed symptomatic chlorosis by 5 days post inoculation (d.p.i.), whereas WT (wild type) remained green (Fig. 1a) . Immunoblot (IB) analysis indicated that crt1-2 crh1-1 supported substantially greater TCV replication than WT, as the dKO contained 12.7-fold more coat protein (CP) in the inoculated leaves than WT at 3 d.p.i. (Fig. 1b) . Fourteen-fold more CP was also detected in the uninoculated tissue of the dKO compared with that in WT, indicating that the virus spread and replicated more readily in the dKO. In addition, the dKO supported 2.7-fold more growth of virulent Pst than WT plants (Fig. 1c , compare mock-pretreated WT versus crt1-2 crh1-1).
Flagellin is a PAMP that is present in a broad range of bacterial pathogens, including Pst 21 ; it triggers the induction of numerous defence-related genes and resistance to pathogens 22 . To assess whether flagellin-induced PTI requires CRT1, WT and dKO plants were pretreated with an epitope of flagellin, flg22, and then infected with Pst. Reduction in Pst growth due to flg22 pretreatment was 50% less in the dKO than in WT (Fig. 1c) , indicating that flg22-induced PTI was partially compromised. Please note that the modest reduction in basal resistance/PTI exhibited by crt1-2 crh1-1 is likely due to the presence of CRH2, which complements the original crt1-1 mutant (unpublished, H.G.K. and D.F.K.).
FLS2 is the receptor that recognizes flagellin 23 . To assess the genetic interaction between FLS2 and CRT1 in PTI, a fls2-101 crt1-2 crh1-1 triple mutant was generated and challenged with Pst. As expected, the fls2 single mutant displayed increased susceptibility to Pst 22 , and pretreatment with flg22 induced little resistance (Fig. 1c) . Similar levels of bacterial growth were observed in mock-and flg22-pretreated triple mutant plants, suggesting that CRT1 and FLS2 function in the same defence signalling pathway.
Whether CRT1 and CRH1 are required for other FLS2-mediated responses was then assessed. Callose deposition, a hallmark of FLS2-mediated PTI, was monitored by inoculating plants with non-pathogenic Pst hrcC, which lacks a functional type III secretion apparatus (an effector delivery system) but carries a collection of PAMPs sufficient to trigger callose deposition 24 . In comparison with WT plants, callose deposition after Pst hrcC infection was reduced about 80% in the dKO and fls2 mutants ( Fig. 1d; Supplementary Fig. S1a ). As enhanced ROS generation is one of the earliest events induced after FLS2 activation by flg22, ROS levels were monitored after flg22 or mock treatment. The dKO displayed reduced ROS generation compared with WT ( Fig. 1e ; Supplementary Fig. S1b ); the total ROS accumulation for 30 min after 1 mM flg22 treatment was 19% lower in the dKO as compared with that in WT ( Supplementary  Fig. S1c ). Continuous activation of FLS2-mediated defence responses due to the presence of flg22 was previously shown to retard root growth in WT, but not fls2 plants 23 . Analysis of the dKO revealed that flg22-induced root growth retardation also was compromised ( Fig. 1f ; Supplementary Fig. S1d ). Together, these results indicate that the CRT1 family affects a broad range of PTI responses. However, the reduced PTI exhibited by dKO plants does not appear to be caused by significant alterations in the transcriptome. Using quantitative real-time RT-PCR, the expression of four widely used PTI marker genes (MYB51, PAD3, PAL1 and FRK) 25 and seven CRA (CRT1-associated) genes (which are differentially expressed in dKO versus WT plants in response to avirulent Pst AvrRpt2 (ref. 13)) was monitored in mock-and flg22-treated dKO and WT plants. Only PAD3 and CRA2 showed small, but statistically significant, reductions in flg22-induced expression in the dKO compared with WT ( Supplementary Fig. S2 ).
CRT1 is involved in non-host resistance and SAR. To investigate whether CRT1 and CRH1 are required for non-host resistance, we monitored symptom severity, the levels of cell death, callose deposition and penetration attempts in dKO and WT plants after P. infestans inoculation. The dKO exhibited elevated levels of chlorosis and cell death, almost comparable to the heightened levels observed in pen2-2 (ref. 7) , whereas little to no cell death was detected in WT ( Fig. 2a,b) . Callose deposition, which is activated in non-host pathogen-inoculated WT, but not in pen2-2 (ref. 6), also was compromised in the dKO ( Fig. 2c ; Supplementary Fig. S3 ). Another measure of non-host resistance is the frequency of successful penetration attempts with initiation of haustoria formation. In contrast to WT, where 75% or more of the leaves had few, if any, detectable penetration attempts, more than half of the dKO or pen2-2 leaves had high numbers of successful attempts resulting in haustorium initials (Fig. 2d) . Together, these results argue that the CRT1 family also has a role in non-host resistance. Whether CRT1/CRH1 also function in SAR was investigated by inoculating three lower leaves of WT, dKO or SAR-deficient bsmt1 (benzoic acid/SA methyl transferase) 2 plants with either buffer (mock) or P. syringae pv. maculicola (Psm) AvrRpt2 cor À . Resistance to a subsequent inoculation with virulent Pst was then monitored. Growth of virulent Pst was reduced 9.7-fold in SARinduced WT, which had received a primary inoculation with Psm AvrRpt2 cor À , as compared with the mock-inoculated control (Fig. 2e) , whereas little reduction in Pst growth was observed in bsmt1. Pst growth in dKO that received a primary infection with Psm AvrRpt2 cor À was 6.2-fold lower than that in mockinoculated dKO, indicating that SAR is partially compromised. Pathogen infection induces SA accumulation in the local and systemic leaves; the increase in uninoculated leaves correlates strongly with SAR development 2 . CRT1/CRH1 do not appear to be required for local SA accumulation in response to Pst avrRpt2 cor À , as SA levels in the inoculated leaves of dKO and WT plants were comparable at 1 d.p.1 i. (Fig. 2f) . However, SA was significantly reduced in the systemic leaves of both dKO and bsmt1 as compared with WT (2.5-and 2.7-fold in dKO and bsmt at 2 d.p.1 i., respectively). Together, these results indicate that the CRT1 family is required for full SAR development.
CRT1 physically associates with FLS2 in planta. To assess whether CRT1 and FLS2 interact, these proteins were tagged with Myc and Flag epitopes, respectively, and then co-expressed in Nicotiana benthamiana via Agro-infiltration. IP of FLS2-Flag using aFlag antibodies revealed that CRT1 physically associates with FLS2, whereas the negative control, Myc-GFP, did not (Fig. 3a) . Reciprocal IP of Myc-CRT1 using aMyc antibodies confirmed that FLS2 physically associates with CRT1 ( Supplementary Fig. S4 ). Interestingly, although activation of R proteins was previously shown to disrupt the R protein-CRT1 interaction 21 , CRT1 remained physically associated with FLS2 after flg22 treatment (Fig. 3a) . Thus, the CRT1-FLS2 interaction may be less dynamic.
The co-chaperones HSP90 and SGT1 are important for R protein stability, as well as for ETI 26, 27 ; thus, the compromised resistance in hsp90 and sgt1 is likely due to R protein instability 26 . In comparison, CRT1 does not seem to affect the stability of R proteins; RPS2 levels in the dKO were comparable to those in WT 13 . Consistent with this finding, IB analysis revealed comparable levels of FLS2 in WT and dKO (Fig. 3b) . No FLS2 was detected in the fls2 or triple mutant, confirming the specificity of the aFLS2 antibody.
Owing to the difficulty in detecting immune receptors at their low endogenous levels, CRT1's interaction with immunity receptors was previously demonstrated using proteins transiently overexpressed in N. benthamiana. However, as the aFLS2 antibody detected endogenous FLS2, the interaction between FLS2 and Myc-tagged genomic CRT1, which was expressed at physiological levels under its own promoter in the dKO background (Myc-gCRT1), was monitored. Note that CRT1 tagged with Myc at its N terminus is fully functional, as it complemented the crt1-1 phenotype 12 . A small quantity of FLS2 was found to co-IP with Myc-CRT1 (Fig. 3c) . Note that FLS2 co-IP with CRT1 migrated B5 kDa slower than input-FLS2 (for example compare lanes 2 versus 4 in Fig. 3c ), suggesting that FLS2 interacting with CRT1 is post-translationally modified. To establish the specificity of this CRT1-FLS2 interaction, agaroseconjugated aMouse antibody was used in the co-IP assay with protein extracts prepared from Myc-gCRT1. In comparison with aMyc, the aMouse antibody failed to co-IP FLS2 (Fig. 3d , lanes 3 and 5 versus 4 and 6). Consistent with the results in Fig. 3a , pretreatment with flg22 did not reduce the CRT1-FLS2 interaction (Fig. 3d) . Together, these results indicate that CRT1 physically associates with FLS2 expressed at physiological levels, and that this interaction is not disrupted by FLS2 activation.
Activation of immune receptors enhances CRT1 accumulation in the nucleus. As CRT1 family members contain two domains characteristic of MORCs, and eukaryotic MORC proteins are associated with the nucleus, the presence of CRT1 in the nucleus was examined. Using Myc-gCRT1 leaves, transmission electron microscopy (TEM) via indirect immunogold labelling revealed immune reactivity with aMyc in cytosolic microbodies/endomembrane-like vesicles ( Supplementary Fig. S5a ), consistent with earlier immunofluorescence analyses using GFP-tagged CRT1 (ref. 13) . TEM also detected CRT1, represented by the gold labels, in the nuclei of mock-and flg22-treated leaves (Fig. 4a-f) . In mock-treated leaves, the nuclear-localized gold labels were evenly distributed, mainly as single particles associated with filamentous, grey structures representing euchromatin fibres. Clustering of gold labels was rarely visible and did not exceed four particles per cluster ( Fig. 4b and Supplementary Fig. S6d ). A comparable labelling pattern was observed in nuclei from untreated MycgCRT1 transgenic plants ( Supplementary Fig. S5b ). Following flg22 treatment, the number of nuclear-localized gold labels, and the number of clusters containing three or more particles, increased significantly ( Fig. 4c-g; Supplementary Fig. S6a-d) . In addition, single particles and clusters of gold label were observed near the nuclear pores of flg22-treated plants, perhaps reflecting nuclear-cytosol shuttling of CRT1 ( Supplementary Fig. S7) ; please note that the postulated shuttle may be rapid, as immunolabelling of nuclear pores was a rare event, which could not be validated by statistical analysis.
The presence of a CRT1 subpopulation in the nucleus was confirmed using subcellular fractionation. In mock-treated MycgCRT1 plants, the nucleus-enriched subcellular fractions contained very low levels of CRT1; B2-fold greater levels were detected in the nucleus-enriched fractions from flg22-treated plants (Fig. 5a) . Similarly, nuclear CRT1 levels were B2-fold higher in Pst hrcC-inoculated Myc-gCRT1 plants than in mock-inoculated plants at 30 min after infection ( Supplementary  Fig. S8 ). As FLS2 activation appears to lead to rapid, modest increases in nuclear CRT1, we tested whether other types of immune activation also influence nuclear CRT1 levels. Interestingly, subcellular fractionation revealed B9-fold increase in nuclear CRT1 by 16 h post inoculation (h.p.i.) with avirulent Pst AvrRpt2 (Fig. 5b) ; this time point was chosen to ensure that ETI was fully activated. By contrast, no increase in nuclear CRT1 levels was detected at 16 h.p.i. with virulent Pst or Pst hrcC. These results indicate that ETI, which triggers the strongest immune response, also promotes the greatest translocation of CRT1 to the nucleus, whereas PTI induces a modest, rapid, and transient increase in nuclear CRT1.
CRT1 is a DNA-binding protein with endonuclease activity. As most eukaryotic and prokaryotic MORC proteins are associated with nucleic acid-modifying activities, we tested whether CRT1 binds DNA and RNA. Nucleic acid binding, when mediated by Trp-residues, can cause a change in the intrinsic fluorescence 28 ; thus, the fluorescence of CRT1 in the absence/presence of two different DNAs and RNAs was monitored. TCV DNA and RNA were included in the binding assay to assess whether CRT1 specifically interacts with them, as TCV resistance requires CRT1. All four nucleic acids quenched the intrinsic fluorescence of recombinant CRT1 (Fig. 6a) , suggesting that CRT1 likely interacts with DNA/RNA in a nonspecific manner. This quenching was greatly suppressed when CRT1 was denatured (Fig. 6b) .
Whether CRT1 exhibits endonuclease activity was then investigated by monitoring the conformation/integrity of supercoiled plasmid DNA after incubation with highly purified recombinant CRT1. To help insure that the endonuclease activity being observed was due to CRT1 rather than a contaminating endonuclease, a couple of precautions were taken. First, recombinant His-tagged CRT1 was subjected to three purification steps including nickel-based affinity chromatography, size fractionation by gel filtration chromatography, and anion exchange chromatography. Second, as a negative control, a truncated version of CRT1 (CRT1-CC) carrying the predicted coil-coiled domain (511-635 a.a.) was purified in parallel with ARTICLE full-length CRT1 and tested for endonuclease activity. Note that coil-coiled domains are often involved in protein-protein interactions, nonspecific as well as specific. In the presence of increasing concentrations of CRT1 or increasing incubation times, the level of supercoiled plasmid DNA was correspondingly reduced (Fig. 7) . Analysis of endonuclease activity in the presence of different divalent cations revealed that CRT1 exhibits a strong preference for Mn 2 þ and, to a lesser degree, Mg 2 þ as a metal cofactor (Fig. 7a,b) . In contrast, little if any endonuclease activity was associated with truncated CRT1-CC (Fig. 7) . Together, these results argue that CRT1 is a nucleic acid-interacting protein with endonuclease activity.
The CRT1 family affects tolerance to mitomycin C. Endonucleases, including the MORC protein MutL, have critical roles in DNA R/R 16,18,29 . To assess whether CRT1/CRH1 are involved in DNA R/R, the dKO was monitored for altered resistance to the DNA-damaging agent, mitomycin C. Consistent with earlier studies, WT plants grown in the presence of mitomycin C exhibited reduced ability to form true leaves 30 . True leaf formation in dKO plants was suppressed to a lesser extent than in WT ( Fig. 8 ; 43% of WT versus 72% of dKO at 80 mM mitomycin C), indicating enhanced mitomycin C tolerance. By contrast, the suppressor of sni1 1 (ssn1) mutant, which carries a mutation in RAD51, a key factor in R/R, was hypersensitive to mitomycin C, as previously reported 30 . This result indicate that the CRT1 family is involved in DNA repair, perhaps as a negative regulator.
Discussion
In this study, we extend our previous findings to show that CRT1 is involved in multiple levels of the immune response. In addition, TEM and subcellular fractionation revealed that a subpopulation of CRT1 is present in the nucleus, and that nuclear CRT1 levels increase following activation of PTI or ETI. Consistent with its nuclear location, CRT1 exhibited DNA-binding and Mn 2 þ -dependent endonuclease activities, which are also found in the MORC protein MutL 29 . These findings, together with CRT1's membership in the MORC superfamily, suggest that it has a role in modifying chromatin/DNA, as shown for animal MORC proteins, including MutL and MORC1 (refs 18,31) . CRT1 interacts in planta with a large number of proteins involved in plant immunity when they are co-expressed in N. benthamiana 12, 13 (Fig. 3) . Recent Arabidopsis genome-wide interactome studies have confirmed these interactions, and suggest that they are indirect, mediated via two bridging proteins 32, 33 . Consistent with these results, a yeast two-hybrid system did not detect direct interaction between CRT1 and R proteins or PAMP-recognition receptors (PRRs; unpublished, H.G.K. and D.F.K.). As FLS2 is predominantly localized in the PM before activation 34 , while the majority of CRT1 is in endomembranes 13 , an interesting question is where these immune proteins interact. Analyses of endoglycosidase H sensitivity 35 have suggested that FLS2, whether expressed in N. benthamiana or Arabidopsis, is present in both the endoplasmic reticulum and PM 36, 37 . Moreover, a portion of FLS2 was found in endomembranes 36 , suggesting the CRT1-FLS2 interaction may occur in this compartment. Supporting this possibility, the animal PRRs TLR9 and TLR4, key factors in modulating innate and adaptive immunity, require localization to endosomes for their functions 38, 39 . Interestingly, TLR4 mediates defence signalling by interacting with MyD88 and TRIF in the PM and endosomes, respectively; the MyD88-and TRIFdependent pathways function synergistically when both are activated 40 . Therefore, it is plausible that CRT1 functions together with FLS2 in endomembranes, whereas a PMassociated population of FLS2 acts through another pathway, perhaps in a synergistic manner.
Nuclear translocation of R proteins and several downstream immune components, including NPR1 and EDS1, has a critical role in plant immunity 41 . CRT1's translocation to the nucleus upon activation of R/PRR proteins strongly suggests a nuclear role(s) for CRT1 in disease resistance. One possible function might be in DNA R/R. Although the importance of DNA R/R in disease has only recently begun to be appreciated in plants and humans 42, 43 , emerging evidence suggests that R/R is involved in pathogen-induced transcriptional reprogramming. For instance, SNI1 (Suppressor of NPR1, Inducible) was proposed to mediate defence gene expression via histone modification 44 . Interestingly, several ssn mutants encode mutated versions of well-established DNA R/R proteins, such as RAD51D (SSN1), SWI/SNF (SSN2) and BRCA2A (SSN3) 30, 45, 46 . Mutations in any of the three SSN genes results in altered induction of pathogen-responsive genes and increased susceptibility/sensitivity to pathogens and DNAdamaging agents. The combined findings that (i) CRT1 exhibits endonuclease activity, (ii) nuclear CRT1 levels increase following R/PRR activation and (iii) crt1-2 crh1-1 displays enhanced tolerance to mitomycin C, suggest that the CRT1 family also functions in modulating DNA R/R, perhaps as a negative regulator, following immune receptor activation. Please note that although tolerance to DNA-damaging agents is reduced in the ssn mutants and enhanced in our dKO, both sets of mutants are compromised for disease resistance. Two independent screens for mutants that are suppressed for gene silencing recently identified CRT1 and its homologue CRH6. Mutations in either of these genes restored the previously silenced expression of a GFP transgene 19, 20 . These findings suggest that CRT1 directly or indirectly modulates RNA silencing. RNA silencing is a critical component of plant immune responses against viral and bacterial pathogens 47 . Many viruses, including TCV, encode proteins that disrupt this defense 48 . In plants, the small RNAs involved in RNA silencing have critical roles in reprogramming host gene expression following infection with various pathogens [49] [50] [51] [52] . Thus, CRT1-mediated RNA silencing may be responsible for at least some of these host responses although most of the defence genes tested were not affected by CRT1/CRH1 (Supplementary Fig. S2 ). It remained to be determined whether functionally redundant CRH2 may have obscured PTI-associated transcriptome changes in dKO.
Although eukaryotic MORC proteins are associated with DNA/chromatin modification 16 , there is no prior evidence suggesting MORC protein involvement in immunity. However, the association of prokaryotic MORCs with restrictionmodification systems, an ancient defence system that discriminates nonself from self DNA, is consistent with this possibility 16 . Here we show for the first time that a eukaryotic MORC, CRT1, is a critical factor in multiple levels of plant immunity. Furthermore CRT1's biochemical activities and differential localization to the nucleus after pathogen challenge suggest that it likely functions in chromatin/DNA modification, which may affect transcriptional reprogramming. Given that transposons and other silenced genes are derepressed in the crt1 and crh6 mutants 19, 20 , and that infection can induce genome instability 53 , which may result from derepression of transposons, we propose that enhanced mobilization of CRT1 to the nucleus after pathogen infection may help regulate transcriptional reprogramming and also maintain genome stability, in part by suppressing the derepression of transposons and/or other silenced genes. Arabidopsis cDNA with the oligonucleotides: 5 0 -GGCGCGCCATGAAGTTACTCTC AAAGACCTTT-3 0 and 5 0 -GGCGCGCCAACTTCTCGATCCTCGTTACGATC-3 0 . Amplified FLS2 fragment was ligated into pER-Flag, creating pER-FLS2-Flag. To generate Myc-gCRT1, the promoter of CRT1 with PacI and AscI sites at each end was amplified using BAC F23E13 and the oligonucleotides: 5 0 -TTAATTAAACTTCTTTA GTCGTTGGTTTCATT-3 0 and 5 0 -GGCGCGCCTACCGACGGCGACAAAACGAA TTC-3 0 . pER-Myc-CRT1 (ref. 12) was digested with AscI and XhoI, to provide a fragment carrying the 6 Â Myc tag and the first 155 bp of CRT1; note that the genomic sequence corresponding to this fragment does not have an intron, and XhoI is a unique site present in CRT1. The 3 0 portion of CRT1 was isolated by digesting BAC F23E13 DNA with XhoI and XbaI; the Xba1 site is located 80 bp 5 0 to the initiation codon for the neighbouring gene, CRH1. These three fragments were sequentially cloned into pPZP-RCS1 carrying a hygromycin resistance marker (hpt) using PacI, AscI, XhoI and XbaI sites 55 , to create pPZP-Myc-gCRT1. The putative CC domain (511-635 a.a.) of CRT1 amplified using the oligonucleotides: 5 0 -GAATTCGTCTGATAGAATCAGTC ATGGTGGTC-3 0 and 5 0 -CTCGAGCTAAACTTGTTGCATCTCCTTCTT-3 0 was ligated into pET28b, creating pET28b-CRT1-CC.
Methods
Co-IP and IB analyses and generation of transgenic plants. Agrobacteriummediated transient expression in N. benthamiana and Agrobacterium-mediated transformation of Arabidopsis were performed as described 12 . Co-IP and IB were performed as described 12 . Equal loading of proteins was checked by staining the polyvinylidene difluoride membrane (Millipore) with Coomassie blue to visualize the large subunit of RuBPCase or by analysing IB with aPEPC (Rockland).
Pathogen infection assays. To examine flg22-induced resistance, the leaves of 4-week-old Arabidopsis plants were infiltrated with water or 0.2 mM flg22 peptide (Genscript). After 24 h, the same leaves were infiltrated with 10 5 c.f.u. ml À 1 of Pst DC3000. Bacterial growth was determined 3 d.p.i. as previously described 12 . TCV inoculation on 4-week-old plants was performed as described 12 . For P. infestans inoculation, isolate US050007, corresponding to the US-11 genotype, was grown on rye B agar at 15 o C and the oomycete sporangia were harvested by washing the plates with sterilized water. The suspension was adjusted to 10 5 sporangia per ml and incubated for 3 h at 4 1C for zoospore release. Four-week-old Arabidopsis plants were sprayed with the sporangia suspension until every leaf appeared evenly wet. Plants were grown at 16 1C with a 16 h-day cycle on trays with a cover to maintain high humidity.
RNA extraction and quantitative real-time RT-PCR. RNA extraction and quantitative real-time RT-PCR was performed as described 13 . The primers for CRA genes 13 and PTI-associated genes 25 were described previously. Each of three biological replicates was analysed in duplicate.
Root extension and ROS generation assay. The root extension assay in the presence of flg22 or water was performed as previously described 23 . The ROS generation assay in the presence of flg22 or water was performed as previously described 56 .
Data quantitation for SA measurements and stainings. SA was extracted and quantified from inoculated leaves as previously described 57 . Trypan blue staining was performed as described previously 12 . Photographs were taken using an Olympus SZX-12 Stereo Microscope. Aniline blue staining was carried out as described previously 58 . Photographs were taken using a Leica DM5500 Epifluorescence Microscope. Cell death, callose deposition and gel images were quantified using the ImageJ (NIH).
Expression and purification of recombinant CRT1. Recombinant CRT1 and CRT1-CC (511-653 a.a.) proteins were expressed in Escherichia coli using pET28b-CRT1 or pET28b-CRT1-CC and purified as previously described, except the following modifications 12 . E. coli strain BL21 cells carrying the respective plasmids were grown at 37 1C to OD 600 ¼ 0.7. Expression of CRT1 was induced by adding 0.1 mM isopropyl-b-D-thiogalactoside for 20 h at 18 1C. The collected cells were resuspended in lysis buffer, buffer A (25 mM HEPES/7.5, 0.5 M NaCl, 2 mM dithiothreitol (DTT), 10% glycerol) containing 10 mM imidazole and phenylmethyl sulphonyl fluoride. After sonication and centrifugation (1 h, 50,000 g, 4 1C), the soluble 6 Â His-tagged CRT1 protein was purified by affinity chromatography using Ni-NTA agarose resin (Novagen); following washing the CRT1-bound resin with buffer A containing 20 mM imidazole, CRT1 was eluted in buffer A containing 300 mM imidazole. The eluted CRT1 was subjected to gel filtration chromatography on a HiLoad 16/60 Superdex 200 column (GE Healthcare) equilibrated in buffer B (50 mM Tris-HCl/7.5, 300 mM NaCl, 2 mM DTT, 10% glycerol). The fraction containing highest amount of purified CRT1 was further purified using anion exchange chromatography on a SOURCE 15Q 4.6/100 PE column (GE Healthcare) equilibrated in buffer C (25 mM Tris-HCl/8.0, 2 mM DTT, 10% glycerol). After washing with buffer C containing 125 mM NaCl, CRT1 was eluted with buffer C containing 500 mM NaCl. Subcellular fractionation and fluorescence spectrometry. Enrichment of plant nuclei was performed as previously described 60 . For fluorescence spectrometry, the protein solution of purified CRT1 was adjusted to a concentration of 10 mg ml À 1 . Following excitation at 280 nm, the emission spectra of CRT1 in the absence or presence of nucleic acid (100 ng l-phage DNA, a plasmid carrying TCV DNA, TCV in vitro transcript or yeast RNA) were recorded from 300 to 400 nm at 20 1C with the band width set to 5 nm. Spectra were accumulated and averaged three times at an acquisition speed of 0.5 nm, and subsequently buffer-corrected. Spectra of the native protein were recorded in buffer B (see expression and purification of recombinant CRT1). For denaturation, the protein solution was exposed to repeated freeze-thaw cycles. 
